Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening | Zendy

Patricia Murphy | Zendy; Dinesh Kumar | Zendy; Gary Zammit | Zendy; Russell Rosenberg | Zendy; Margaret Moline | Zendy

Open Access

Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening

Author(s) -

Patricia Murphy,

Dinesh Kumar,

Gary Zammit,

Russell Rosenberg,

Margaret Moline

Publication year - 2020

Publication title -

journal of clinical sleep medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.529

H-Index - 92

eISSN - 1550-9397

pISSN - 1550-9389

DOI - 10.5664/jcsm.8294

Subject(s) - morning , zolpidem , placebo , cognition , medicine , crossover study , psychology , audiology , psychiatry , insomnia , alternative medicine , pathology

Our aim was to evaluate the effect of lemborexant versus zolpidem tartrate extended release 6.25 mg (ZOL) or placebo (PBO) on postural stability, auditory awakening threshold (AAT), and cognitive performance (cognitive performance assessment battery [CPAB]).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research